Seminars in Respiratory and Critical Care Medicine

Article	Citations
Long-Term Antibiotics in Bronchiectasis	62
Monographic Issue on Pulmonary Hypertension: Medical and Interventional Treatment for Chronic Thromboembolic Pulmonary Hypertension	55
Improving Medication Adherence in Asthma	43
State of the Art and Emerging Technologies in Vaccine Design for Respiratory Pathogens	41
Sleep, Circadian Rhythms, and Lung Cancer	39
Mechanical Ventilation for COVID-19 Patients	38
Impact of Digital Technologies on Clinical Care for Adults with Cystic Fibrosis	33
Primary Ciliary Dyskinesia	31
Severe Infections Due to Respiratory Viruses	29
	28
Nonmalignant Pleural Effusions	28
Impact of Marijuana Use on Lung Health	26
Advances in the Understanding and Management of Chronic Obstructive Pulmonary Disease	19
Lung Transplant for Chronic Obstructive Pulmonary Disease	18
Prevention of Aspiration: Oral Care, Antibiotics, Others	17
Pseudomonas aeruginosa in Bronchiectasis	16
Chronic Obstructive Pulmonary Disease and Work: The Continuing Narrative	14
The Lung Allocation Score and Its Relevance	14
Imaging in the Intensive Care Unit	14
Fulminant Clostridioides difficile Infection: A Review of Treatment Options for a Life-Threatening Infection	13
Antibiotic Strategies for Severe Community-Acquired Pneumonia	13
Indwelling Pleural Catheter: Management of Complications	13
Deployment-Related Respiratory Disease: Where Are We?	12
COVID-19-Related Pleural Diseases	12
Chronic Pulmonary Aspergillosis: Clinical Presentation and Management	12

	11
Pulmonary Physiology and Medicine of Diving	11
Diagnostic Approach to Interstitial Lung Diseases Associated with Connective Tissue Diseases	11
	11
Any Role of High-Dose Vitamin C for Septic Shock in 2021?	11
Definition and Epidemiology of Sepsis	11
The Oral–Lung Microbiome Axis in Connective Tissue Disease-Related Interstitial Lung Disease	11
Clinical Manifestation and Treatment of Allergic Bronchopulmonary Aspergillosis	11
Update on Sepsis Epidemiology in the Era of COVID-19	11
Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease Overlap Syndrome	10
Methicillin-Resistant Staphylococcus aureus Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia	10
Tissue Perfusion and Diffusion and Cellular Respiration: Transport and Utilization of Oxygen	10
Management of Pulmonary Hypertension Associated with Chronic Lung Disease	10
Beyond the Lungs—Emerging Challenges in Adult Cystic Fibrosis Care	10
Blood Gas Transport: Implications for O2 and CO2 Exchange in Lungs and Tissues	9
Understanding the Updates in the Asthma Guidelines	9
Work-Related Sleep Disorders: Causes and Impacts	9
Acute Rejection in the Modern Lung Transplant Era	8
Evidence for the Application of Sepsis Bundles in 2021	8
Novel Therapeutic Approaches in Connective Tissue Disease-Associated Interstitial Lung Disease	8
Diagnosis and Management of Invasive Candida Infections in Critically Ill Patients	8
Chronic Lung Allograft Dysfunction: Evolving Concepts and Therapies	8
How to Survive Sepsis: Patient Testimonial	8
Common Variable Immunodeficiency and Other Immunodeficiency Syndromes in Bronchiectasis	8
Malignant Central Airway Obstruction: What's New?	8
Bronchoscopic Lung Volume Reduction: A Review	8
Clinical Features of COVID-19 and Differentiation from Other Causes of CAP	7
Comorbid Insomnia and Sleep Apnea (COMISA): from research to clinical practice	7
Arterial Blood Gases and Acid–Base Regulation	7
Aspergillus and the Lung	7
Interstitial Lung Disease Associated with Systemic Sclerosis	7
Management of Acutely Decompensated Pulmonary Hypertension	7
Life-Threatening Infections: Pulmonary and Systemic Infections	7
Community-Acquired Pneumonia: Postpandemic, Not Post-COVID-19	7
Intra-abdominal Infections	7
The Deteriorating Patient: Therapies Including Lung Transplantation	7
Bronchiectasis Exacerbations: Definitions, Causes, and Acute Management	7
Sleep and Circadian-Related Outcomes after Critical Illness	6
Pulmonary Hypertension in Connective Tissue Diseases Other than Systemic Sclerosis	6
“Long Haulers”	6
Aspiration Pneumonia: Preface	6
Invasive Pulmonary Aspergillosis in Hospital and Ventilator-Associated Pneumonias	6
Imaging in Asthma Management	6
Pseudomonas aeruginosa Pneumonia: Evolution of Antimicrobial Resistance and Implications for Therapy	6
Defining Clinical and Microbiological Nonresponse in Ventilator-Associated Pneumonia	6
	6
Pulmonary Hypertension Associated with Left Heart Disease	6
Early Diagnosis of Sepsis: The Role of Biomarkers and Rapid Microbiological Tests	6
Cardiovascular Complications in Coronavirus Disease 2019—Pathogenesis and Management	6
Use of Antiviral Agents and other Therapies for COVID-19	6

Pathological Diagnosis of Pulmonary Aspergillosis	6
Severe Community-Acquired Pneumonia	6
Severe Community-Acquired Pneumonia in Immunocompromised Patients	6
HIV and COVID-19 Disease	6
Viral Ventilator-Associated Pneumonia/Hospital-Acquired Pneumonia	6
Control of Breathing	6
Advances in Disease-Modifying Therapeutics for Chronic Neuromuscular Disorders	5
The Role of Viral Infections in the Development and Progression of COPD	5
Chronic Pulmonary Aspergillosis as a Considerable Complication in Post-Tuberculosis Lung Disease	5
Interventional Pulmonology and the Esophagus: Tracheostomy and Percutaneous Endoscopic Gastrostomy Placement	5
Selection Criteria for Lung Transplantation: Controversies and New Developments	5
Gas Exchange in the Lung	5
Vaccination against Respiratory Infections in the Immunosenescent Older Adult Population: Challenges and Opportunities	5
Intrapleural Anticancer Therapy for Malignant Pleural Diseases: Facts or Fiction?	5
Safety, Efficacy, and Effectiveness of Maternal Vaccination against Respiratory Infections in Young Infants	5
Approach to Pulmonary Nodules in Connective Tissue Disease	5
Global Trends in Occupational Lung Disease	5
Nebulized Antibiotics for Healthcare- and Ventilator-Associated Pneumonia	4
Chronic Thromboembolic Pulmonary Disease and Chronic Thromboembolic Pulmonary Hypertension	4
Clinical Epidemiology of Pediatric Coronavirus Disease 2019 and its Postacute Sequelae	4
Navigating COPD in Aging Populations: Insights Into Pathophysiology and Comprehensive Care	4
HAP and VAP after Guidelines	4
Severe Community-Acquired Pneumonia: Noninvasive Mechanical Ventilation, Intubation, and HFNT	4
The Spectrum of Pulmonary Aspergillosis	4
What Is the Role of Steroids for Septic Shock in 2021?	4
	4
Skin Cancers and Lung Transplant	4
Pleural Diseases in Connective Tissue Diseases	4
Phenotyping, Precision Medicine, and Asthma	4
COVID-19 in Immunocompromised Patients: A Systematic Review	4
Malignant Pleural Effusions in the Era of Immunotherapy and Antiangiogenic Therapy	4
Bacteriology of Aspiration Pneumonia: The Lung Microbiome and the Changing Microbial Etiology	4
Pulmonary Vascular Disease in Chronic Obstructive Pulmonary Disease	4
Risk of Multidrug-Resistant Pathogens in Severe Community-Acquired Pneumonia	4
Mediastinal Staging with Endobronchial Ultrasound in Early-Stage Non—Small Cell Lung Cancer: Is It Necessary?	4
Expert Review on Spontaneous Pneumothorax: Advances, Controversies, and New Directions	3
Aspiration after Critical Illness: Role of Endotracheal Tube, Tracheostomy, and Swallowing Disorders	3
High-Resolution Computed Tomography of Cystic Lung Disease	3
Overview of Rheumatoid Arthritis-Associated Interstitial Lung Disease and Its Treatment	3
	3
	3
Nutrition in Asthma	3
Swallowing and Aspiration: How to Evaluate and Treat Swallowing Disorders Associated with Aspiration Pneumonia in Older Persons	3
Early Experience on Universal Prophylaxis in Infants against Respiratory Syncytial Virus: Facts and Expectations	3
Optimizing Fluid Resuscitation and Preventing Fluid Overload in Patients with Septic Shock	3
	3
Management of Severe Influenza	3
Corrigendum: Severe Community-Acquired Pneumonia: Noninvasive Mechanical Ventilation, Intubation, and HFNT	3
	3
Ventilation Mechanics	3
Environmental Interventions for Asthma	3
Evaluation of Neuromuscular Disease in Adults Presenting with Dyspnea	3
Cystic Fibrosis	3
Transmission and Risk Factors of COVID-19 among Health Care Workers	3
	3
COVID-19 Vaccines—All You Want to Know	3
Bronchoscopic Lung Volume Reduction for Emphysema: Review and Update	3
Dysregulation of Host–Pathogen Interactions in Sepsis: Host-Related Factors	3
Importance of and Approach to Taking a History of Exposures to Occupational Respiratory Hazards	3
Diagnosis and Initial Investigation of Bronchiectasis	3
Imaging of Lung Disease Associated with Connective Tissue Disease	3
Systemic Lupus Erythematosus-related Lung Disease	3
Medical Emergencies in Pulmonary Hypertension	3
Aspiration Pneumonia	3
Techniques for Oxygenation and Ventilation in Coronavirus Disease 2019	3
Modeling Mechanical Ventilation In Silico—Potential and Pitfalls	3
New Insights in the Pathophysiology of Hospital- and Ventilator-Acquired Pneumonia: A Complex Interplay between Dysbiosis and Critical-Illness–Related Immunosuppression	2
Antimicrobial Strategies for Cystic Fibrosis	2
Middle East Respiratory Syndrome Coronavirus	2
Review of Pulmonary Physiology	2
Extracorporeal Membrane Oxygenation as a Bridge to Lung Transplant	2
Artificial Intelligence in Quantitative Chest Imaging Analysis for Occupational Lung Disease	2
Pulmonary Aspergillosis in People with Cystic Fibrosis	2
New Antibiotics for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia	2
Sepsis from Science to Social Perspective	2
Aspiration after Anesthesia: Chemical versus Bacterial, Differential Diagnosis, Management, and Prevention	2
Integrated Multiorgan Bedside Ultrasound for the Diagnosis and Management of Sepsis and Septic Shock	2
Bronchiectasis: Advances in Diagnosis and Treatment	2
Management of Chronic Neuromuscular Respiratory Failure in the Intensive Care Unit	2
Glucocorticoid Therapy in COVID-19	2

Management of Pulmonary Arterial Hypertension	2
Nonmalignant Central Airway Obstruction: Options for Challenging Cases	2
Nontuberculous Mycobacteria in Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Regulator Modulators	2
Epigenetic Mechanisms in Sepsis-Associated Acute Kidney Injury	2
Viral Respiratory Infections: From Bench to Bedside	2
Five Questions to Help Prompt End-of-Life Planning in Neuromuscular Disease	2